Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

Joseph A. Blansfield, Kimberly E. Beck, Khoi Tran, James C. Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Suzanne Topalian, Leah R. Haworth, Catherine Levy, Steven A. Rosenberg, Richard M. Sherry

Research output: Contribution to journalArticle

Abstract

Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is an immunoregulatory molecule expressed by activated T cells and resting CD4+CD25 + T cells. In patients with advanced melanoma, our group reported that administration of anti-CTLA-4 antibody mediated objective cancer regression in 13% of patients. This study also established that the blockade of CTLA-4 was associated with grade III/IV autoimmune manifestations that included dermatitis, enterocolitis, hepatitis, uveitis, and a single case of hypophysitis. Since this initial report, 7 additional patients with anti-CTLA-4 antibody-induced autoimmune hypophysitis have been accumulated. The characteristics, clinical course, laboratory values, radiographic findings, and treatment of these 8 patients are the focus of this report.

Original languageEnglish (US)
Pages (from-to)593-598
Number of pages6
JournalJournal of Immunotherapy
Volume28
Issue number6
StatePublished - Nov 2005
Externally publishedYes

Fingerprint

CTLA-4 Antigen
Kidney Neoplasms
Melanoma
T-Lymphocytes
Enterocolitis
Antibodies
Uveitis
Dermatitis
Hepatitis
Autoimmune Hypophysitis
Neoplasms
Thomsen-Friedenreich antibodies

Keywords

  • Anti-CTLA-4 antibody
  • Autoimmune hypophysitis
  • Autoimmunity
  • Immunotherapy
  • Melanoma
  • Renal cell cancer

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Immunology

Cite this

Blansfield, J. A., Beck, K. E., Tran, K., Yang, J. C., Hughes, M. S., Kammula, U. S., ... Sherry, R. M. (2005). Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. Journal of Immunotherapy, 28(6), 593-598.

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. / Blansfield, Joseph A.; Beck, Kimberly E.; Tran, Khoi; Yang, James C.; Hughes, Marybeth S.; Kammula, Udai S.; Royal, Richard E.; Topalian, Suzanne; Haworth, Leah R.; Levy, Catherine; Rosenberg, Steven A.; Sherry, Richard M.

In: Journal of Immunotherapy, Vol. 28, No. 6, 11.2005, p. 593-598.

Research output: Contribution to journalArticle

Blansfield, JA, Beck, KE, Tran, K, Yang, JC, Hughes, MS, Kammula, US, Royal, RE, Topalian, S, Haworth, LR, Levy, C, Rosenberg, SA & Sherry, RM 2005, 'Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer', Journal of Immunotherapy, vol. 28, no. 6, pp. 593-598.
Blansfield, Joseph A. ; Beck, Kimberly E. ; Tran, Khoi ; Yang, James C. ; Hughes, Marybeth S. ; Kammula, Udai S. ; Royal, Richard E. ; Topalian, Suzanne ; Haworth, Leah R. ; Levy, Catherine ; Rosenberg, Steven A. ; Sherry, Richard M. / Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. In: Journal of Immunotherapy. 2005 ; Vol. 28, No. 6. pp. 593-598.
@article{fbd75ebe22144361abf63f0504f0768e,
title = "Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer",
abstract = "Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is an immunoregulatory molecule expressed by activated T cells and resting CD4+CD25 + T cells. In patients with advanced melanoma, our group reported that administration of anti-CTLA-4 antibody mediated objective cancer regression in 13{\%} of patients. This study also established that the blockade of CTLA-4 was associated with grade III/IV autoimmune manifestations that included dermatitis, enterocolitis, hepatitis, uveitis, and a single case of hypophysitis. Since this initial report, 7 additional patients with anti-CTLA-4 antibody-induced autoimmune hypophysitis have been accumulated. The characteristics, clinical course, laboratory values, radiographic findings, and treatment of these 8 patients are the focus of this report.",
keywords = "Anti-CTLA-4 antibody, Autoimmune hypophysitis, Autoimmunity, Immunotherapy, Melanoma, Renal cell cancer",
author = "Blansfield, {Joseph A.} and Beck, {Kimberly E.} and Khoi Tran and Yang, {James C.} and Hughes, {Marybeth S.} and Kammula, {Udai S.} and Royal, {Richard E.} and Suzanne Topalian and Haworth, {Leah R.} and Catherine Levy and Rosenberg, {Steven A.} and Sherry, {Richard M.}",
year = "2005",
month = "11",
language = "English (US)",
volume = "28",
pages = "593--598",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

AU - Blansfield, Joseph A.

AU - Beck, Kimberly E.

AU - Tran, Khoi

AU - Yang, James C.

AU - Hughes, Marybeth S.

AU - Kammula, Udai S.

AU - Royal, Richard E.

AU - Topalian, Suzanne

AU - Haworth, Leah R.

AU - Levy, Catherine

AU - Rosenberg, Steven A.

AU - Sherry, Richard M.

PY - 2005/11

Y1 - 2005/11

N2 - Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is an immunoregulatory molecule expressed by activated T cells and resting CD4+CD25 + T cells. In patients with advanced melanoma, our group reported that administration of anti-CTLA-4 antibody mediated objective cancer regression in 13% of patients. This study also established that the blockade of CTLA-4 was associated with grade III/IV autoimmune manifestations that included dermatitis, enterocolitis, hepatitis, uveitis, and a single case of hypophysitis. Since this initial report, 7 additional patients with anti-CTLA-4 antibody-induced autoimmune hypophysitis have been accumulated. The characteristics, clinical course, laboratory values, radiographic findings, and treatment of these 8 patients are the focus of this report.

AB - Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is an immunoregulatory molecule expressed by activated T cells and resting CD4+CD25 + T cells. In patients with advanced melanoma, our group reported that administration of anti-CTLA-4 antibody mediated objective cancer regression in 13% of patients. This study also established that the blockade of CTLA-4 was associated with grade III/IV autoimmune manifestations that included dermatitis, enterocolitis, hepatitis, uveitis, and a single case of hypophysitis. Since this initial report, 7 additional patients with anti-CTLA-4 antibody-induced autoimmune hypophysitis have been accumulated. The characteristics, clinical course, laboratory values, radiographic findings, and treatment of these 8 patients are the focus of this report.

KW - Anti-CTLA-4 antibody

KW - Autoimmune hypophysitis

KW - Autoimmunity

KW - Immunotherapy

KW - Melanoma

KW - Renal cell cancer

UR - http://www.scopus.com/inward/record.url?scp=27444440093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27444440093&partnerID=8YFLogxK

M3 - Article

C2 - 16224277

AN - SCOPUS:27444440093

VL - 28

SP - 593

EP - 598

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 6

ER -